semaglutide biomarkers alzheimer evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic Alzheimer's disease | Alzheimer's Research & Therapy Weight Loss Drug Semaglutide Shows
Description
Individuals with prior peripheral neuropathy, diabetes, or inflammatory conditions may require modified protocols or enhanced monitoring
[DOI] [PubMed] [Google Scholar] Godoy-Matos AF
Retail data tells a similar story, and it is good news for dairy
It was originally developed to treat type 2 diabetes, but it has become popular due to its off-label use as a weight loss drug
They also might not have enough supply of the treatment, or funds to support an expanded access program
It's always good to be wary of anything promising to magically reduce your waistline
